Literature DB >> 3545950

Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.

T Kobayashi, T Itoh, K Kosaka, K Sato, K Tsuji.   

Abstract

The time course of islet cell antibodies (ICA) and serum C-peptides responses (CPRs) to oral glucose tolerance tests (OGTTs) were studied prospectively up to 60 (mean 35) mo in 32 ICA-positive subjects [28 with non-insulin-dependent diabetes (NIDDM) and 4 subjects with impaired glucose tolerance (IGT); mean age 45 yr], 96 matched subjects [56 with NIDDM, 8 with IGT, and 32 normal first-degree relatives of patients with insulin-dependent diabetes (IDDM); mean age 45 yr] who were negative for ICA at the beginning of the study. In addition, the effects of human leukocyte antigens (HLA) on the time course of ICA and beta-cell function were evaluated. In 10 subjects (8 with NIDDM and 2 with IGT) who were ICA positive, ICA became undetectable, even by sensitive ICA assay, 15 +/- 2 mo (mean +/- SE) after initiation of this study. In these subjects, integrated serum CPR values (sigma CPR) and 2-h blood glucose values in response to OGTTs improved significantly (P less than .05-.01). In contrast, the remaining 22 subjects who were ICA positive were persistently positive for ICA. CPR and blood glucose responses deteriorated progressively in these 22 subjects, and 7 subjects in this group progressed to the insulin-dependent state. Serum CPR and blood glucose responses to OGTTs showed no remarkable changes in 64 patients (56 with NIDDM and 8 with IGT) and 32 normal first-degree relatives of patients with IDDM who remained negative for ICA throughout the study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545950     DOI: 10.2337/diab.36.4.510

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

1.  GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.

Authors:  E Hatziagelaki; C Jaeger; E Maeser; R G Bretzel; K Federlin
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

2.  Insulin binding substances, autoimmunity and type I diabetes in Kuwaiti patients and their kindred.

Authors:  E R Richens; A Shaltout; G M Bahr; N Abdella; A K Jayyab; M Al-Saffar; K Behbehani
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

Review 3.  Type 1 diabetes in Japan.

Authors:  E Kawasaki; N Matsuura; K Eguchi
Journal:  Diabetologia       Date:  2006-03-28       Impact factor: 10.122

4.  Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243.

Authors:  T Kobayashi; Y Oka; H Katagiri; A Falorni; A Kasuga; I Takei; K Nakanishi; T Murase; K Kosaka; A Lernmark
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

5.  Subtype of islet cell antibodies and slowly progressive beta-cell failure.

Authors:  T Kobayashi; K Nakanishi; T Murase; K Kosaka
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

6.  Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  T Kobayashi; K Nakanishi; H Kajio; S Morinaga; T Sugimoto; T Murase; K Kosaka
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

7.  Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  L Niskanen; J Karjalainen; H Sarlund; O Siitonen; M Uusitupa
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

8.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.

Authors:  N Itoh; T Hanafusa; A Miyazaki; J Miyagawa; K Yamagata; K Yamamoto; M Waguri; A Imagawa; S Tamura; M Inada
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus.

Authors:  R Torella; T Salvatore; D Cozzolino; F Grandillo; D Giugliano
Journal:  Acta Diabetol Lat       Date:  1988 Apr-Jun

10.  Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.

Authors:  W A Hagopian; A E Karlsen; A Gottsäter; M Landin-Olsson; C E Grubin; G Sundkvist; J S Petersen; E Boel; T Dyrberg; A Lernmark
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.